会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • INTRAVENOUS INJECTION SITE SPLIT SEPTUM AND PRESSURE ACTIVATED FLOW CONTROL VALVE
    • 静脉注射场分离和压力活化流量控制阀
    • WO2007112278A3
    • 2008-03-06
    • PCT/US2007064695
    • 2007-03-22
    • NEXUS MEDICAL LLCWINSOR CHRISSMITH LARRY CDIKEMAN W CARY
    • WINSOR CHRISSMITH LARRY CDIKEMAN W CARY
    • A61M39/10
    • A61M39/045A61M39/10A61M39/24A61M39/26A61M2039/1027A61M2039/1072A61M2039/242A61M2039/2426Y10T29/49826
    • An improved injection site (12) for infusion of parenteral fluids and the like is provided, having a pressure-actuated valve (20) and a novel split septum unit (24), which effectively prevent reflux of blood into the assembly (10). The septum unit (24) includes a resilient split septum body (64) which is precompressed so that the septum body (64) is caused to protrude proximally (78) upon insertion of a cannula (16). Consequently, upon removal of the cannula (16), there is essentially no "drumming" or creation of friction-induced negative pressures sufficient to generate blood reflux. The preloaded septum body (64) also has its proximal surface (74) essentially flush and coplanar with the adjacent proximal end (66b) of the tubular septum holder (66) to enhance the cleanliness of the unit (24). The specialized well (46) and septum unit (24) afford a resilient seal between the periphery of the septum body (64) and the surface (50), and a separate hard-surface seal between the outer margin of the surface (50) and the septum holder (66).
    • 提供了用于输注肠胃外流体等的改进的注射部位(12),其具有压力致动阀(20)和新颖的分隔隔膜单元(24),其有效地防止血液回流到组件(10)中。 隔膜单元(24)包括弹性分隔隔膜体(64),其被预压缩,使得在插入插管(16)时使隔膜体(64)向近侧突出(78)突出。 因此,在去除插管(16)时,基本上不存在足以产生血液回流的摩擦引起的负压的“打击”或产生。 预加载的隔膜体(64)还具有其近端表面(74)与管状隔膜保持器(66)的相邻近端(66b)基本上齐平并且共面,以增强单元(24)的清洁度。 专用井(46)和隔膜单元(24)在隔膜体(64)的周边和表面(50)之间提供弹性密封,并且在表面(50)的外边缘之间分开的硬表面密封, 和隔膜支架(66)。
    • 4. 发明申请
    • INTRAVENOUS INJECTION SITE SPLIT SEPTUM AND PRESSURE ACTIVATED FLOW CONTROL VALVE
    • 静脉注射场分离和压力活化流量控制阀
    • WO2007112278A2
    • 2007-10-04
    • PCT/US2007/064695
    • 2007-03-22
    • NEXUS MEDICAL, LLC.WINSOR, ChrisSMITH, Larry, C.DIKEMAN, W., Cary
    • WINSOR, ChrisSMITH, Larry, C.DIKEMAN, W., Cary
    • A61M5/178A61M39/10
    • A61M39/045A61M39/10A61M39/24A61M39/26A61M2039/1027A61M2039/1072A61M2039/242A61M2039/2426Y10T29/49826
    • An improved injection site (12) for infusion of parenteral fluids and the like is provided, having a pressure-actuated valve (20) and a novel split septum unit (24), which effectively prevent reflux of blood into the assembly (10). The septum unit (24) includes a resilient split septum body (64) which is precompressed so that the septum body (64) is caused to protrude proximally (78) upon insertion of a cannula (16). Consequently, upon removal of the cannula (16), there is essentially no "drumming" or creation of friction-induced negative pressures sufficient to generate blood reflux. The preloaded septum body (64) also has its proximal surface (74) essentially flush and coplanar with the adjacent proximal end (66b) of the tubular septum holder (66) to enhance the cleanliness of the unit (24). The specialized well (46) and septum unit (24) afford a resilient seal between the periphery of the septum body (64) and the surface (50), and a separate hard-surface seal between the outer margin of the surface (50) and the septum holder (66).
    • 提供了用于输注肠胃外流体等的改进的注射部位(12),其具有压力致动阀(20)和新颖的分隔隔膜单元(24),其有效地防止血液回流到组件(10)中。 隔膜单元(24)包括弹性分隔隔膜体(64),其被预压缩,使得在插入插管(16)时使隔膜体(64)向近侧突出(78)突出。 因此,在去除插管(16)时,基本上不存在足以产生血液回流的摩擦引起的负压的“打击”或产生。 预加载的隔膜体(64)还具有其近端表面(74)与管状隔膜保持器(66)的相邻近端(66b)基本上平齐并共面以增强单元(24)的清洁度。 专用井(46)和隔膜单元(24)在隔膜体(64)的周边和表面(50)之间提供弹性密封,并且在表面(50)的外边缘之间分开的硬表面密封, 和隔膜支架(66)。